Delivery Order SPE2DB22D1017-SPE2DB25FG8MV
- Not listed
- The Defense Logistics Agency awarded a $2,601.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 22, 2025. This non-competitive delivery order represents a single pharmaceutical procurement from the company's extensive federal contract portfolio. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $2,601.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) with an ultimate completion date of August 1, 2025. This non-set-aside contract represents a single delivery order fulfillment of this pharmaceutical product, which is commonly used for osteoporosis treatment. The award was made to AmerisourceBergen's Corporate Office division, based in Conshohocken, Pennsylvania, where the place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,601.43 to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.32 to AmerisourceBergen Drug Corp for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections. The contract, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its...
- The Defense Logistics Agency awarded a $22,503.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This is a non-set-aside competitive award with an ultimate completion date of April 22, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,749.98 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of September 11, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Forteo is a pharmaceutical product used to treat osteoporosis and bone-related...
- The Defense Logistics Agency (DLA) awarded a $59,949.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (teriparatide) 560 mcg/2.24 mL pen injections, with an ultimate completion date of April 25, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order for pharmaceutical supply supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a $16,156.03 firm fixed price delivery order to AmerisourceBergen Drug Corp for Forteo 560 mcg/2.24 mL pen injections on May 30, 2025, with an ultimate completion date of June 2, 2025. This is a non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $20,336.33 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Forteo (560 mcg/2.24 mL pen injections), a pharmaceutical product used to treat osteoporosis. The contract was competitively awarded without set-aside designation and has an ultimate completion date of July 22, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a $17,249.94 delivery order to AmerisourceBergen Drug Corp for the supply of Forteo 560 mcg/2.24 ml pen injections with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8MVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,601.43 to supply Forteo (teriparatide) 560 mcg/2.24 mL pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 31, 2025, and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's $1 billion prime IDC (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen supplies a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to federal customers including the Defense Health Agency and U.S. Coast Guard. The Forteo injection, used primarily for treating osteoporosis, represents one of the specialty pharmaceutical products delivered through this established contract relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 7/30/25 |